Lifepro Asset Management / SRPT
Lifepro Asset Management’s Sarepta Therapeutics Inc Position
Does Lifepro Asset Management own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 41.7K shares worth $5M in Q3 2022; the fund’s latest 13F (Q3 2024) no longer reports it.
Position Value
$5M
Q3 2022
Shares
41.7K
% of Portfolio
+2.65%
Quarters Held
1
position exited
Position History SRPT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 41.7K | $5M | +2.65% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lifepro Asset Management’s full portfolio or all institutional holders of SRPT.